Author:
Mangarule S.,Palkar S.,Mitra M.,Ravi M.D.,Dubey A.P.,Moureau A.,Jayanth M.V.,Patel D.M.,Ravinuthala S.,Jagga S.R.,Patnaik B.N.,Jordanov E.,Noriega F.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference23 articles.
1. Combination vaccines;Decker,2018
2. New perspectives for hexavalent vaccines;Obando-Pacheco;Vaccine,2018
3. Global Polio Eradication Inititative. The polio endgame strategy 2019-2023: eradication, integration, containment and certification. Available from: https://polioeradication.org/who-we-are/polio-endgame-strategy-2019-2023/. Accessed 19 August 2021.
4. Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries;Mahmood;Hum Vacc Immunotherapeut,2013
5. Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants;Gandhi;Hum Vacc Immunotherapeut,2016
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antibody Persistence Following Administration of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T and IPV Vaccines and Safety and Immunogenicity of a Booster Dose of DTwP-IPV-HB-PRP~T Administered With an MMR Vaccine in Healthy Infants in India;Pediatric Infectious Disease Journal;2023-10-13
2. Immunogenicity and Safety of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T, bOPV, and IPV Vaccines Administered at 2, 4, 6 Months of Age Concomitantly With Rotavirus and Pneumococcal Conjugate Vaccines in Healthy Infants in Thailand;Pediatric Infectious Disease Journal;2023-04-27
3. Poliovirus Vaccine—Inactivated;Plotkin's Vaccines;2023
4. Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication;Human Vaccines & Immunotherapeutics;2022-12-28
5. Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6–8, 10–12, and 14–16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study;Vaccine: X;2022-12